PMPRB announces next steps in Guidelines consultation process
Safety Classified by Officially
The Patented Medicine Prices Review Board (PMPRB) will launch the first phase of consultations on its new Guidelines by inviting stakeholders to participate in a Policy Roundtable.
October 25, 2023 — Ottawa, ON — Patented Medicine Prices Review Board
The Patented Medicine Prices Review Board (PMPRB) will launch the first phase of consultations on its new Guidelines by inviting stakeholders to participate in a Policy Roundtable on December 5 (English session) and December 6 (French session).
The intent of this phase is to foster a productive conversation, where all parties can voice their opinions and concerns.
At the Roundtable, stakeholders will be invited to share their views on the development of new Guidelines. The Board is seeking views on the following themes:
A scoping paper will be published ahead of the Roundtable, outlining each theme and the specific questions on which the PMPRB is seeking feedback to assist in developing new Guidelines. Details regarding participation at the Roundtable (in person or virtually) will be included in the scoping paper.
After the first phase of consultations is completed, a ‘’what we heard’’ report will be published.
Interested stakeholders are encouraged to follow the PMPRB on X (formerly Twitter), to stay informed of new developments and announcements.
The Guidelines explain the procedures used by staff at the PMPRB when monitoring the prices of patented medicines. In particular, they explain the criteria staff will consider in determining whether the price of a patented medicine warrants a more in-depth review in the form of an investigation.
This is an extract. The publication continues at the source.
Source: Patented Medicine Prices Review Board. Licence
Read the original at the source: https://www.canada.ca/en/patented-medicine-prices-review/news/2023/10/pmprb-announces-next-steps-in-guidelines-consultation-process.html
Officially imported this from Patented Medicine Prices Review Board’s own source and shows an extract. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.
Provenance
- Organization
- Patented Medicine Prices Review Board — imported from official source
- Official source
- https://api.io.canada.ca/io-server/gc/news/en/v2?dept=patentedmedicinepricesreviewboard&sort=publishedDate&orderBy=desc&publishedDate%3E=2021-07-23&pick=50&format=atom&atomtitle=Patented%20Medicine%20Prices%20Review%20Board ATOM
- Imported
- October 03, 2026 20:43
- Versions
- 1 recorded
- Identity
-
https://www.canada.ca/en/patented-medicine-prices-review/news/2023/10/pmprb-announces-n...